RY 172.93 -0.271% SHOP 157.86 0.7274% TD 75.22 0.2532% ENB 59.74 0.5216% BN 81.36 0.9429% TRI 234.42 0.5404% CNQ 43.01 1.2% CP 104.55 0.7225% CNR 146.44 0.7568% BMO 139.17 0.2377% BNS 77.04 -0.0649% CSU 4487.8101 0.7917% CM 91.94 -0.6054% MFC 44.04 1.1716% ATD 80.33 -0.5694% NGT 54.77 -0.635% TRP 66.14 0.532% SU 50.335 1.4819% WCN 245.2 -2.104% L 191.84 0.64%

Tilray Inc

Healthcare CA TLRY

2.07CAD
0.29(16.29%)

Last update at 2024-12-23T19:16:00Z

Day Range

1.892.07
LowHigh

52 Week Range

1.954.00
LowHigh

Fundamentals

  • Previous Close 1.78
  • Market Cap1761.41M
  • Volume3012044
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA31.12M
  • Revenue TTM812.04M
  • Revenue Per Share TTM1.03
  • Gross Profit TTM 116.82M
  • Diluted EPS TTM-0.37

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Type yearly yearly yearly yearly yearly
Date 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Income before tax -1450.18100M -440.67400M -344.98600M -58.19245M -11.56319M
Minority interest -9.65600M -42.66900M 6.24M 26.96M 21.02M
Net income -1443.00000M -434.13200M -336.01400M -61.01639M -12.19438M
Selling general administrative 230.94M 162.80M 111.58M 88.30M 70.83M
Selling and marketing expenses - 65.86M 44.12M 29.92M 20.67M
Gross profit 146.96M 116.82M 123.18M 137.68M 55.74M
Reconciled depreciation 130.15M 115.19M 67.83M 49.27M 22.94M
Ebit - 153.29M -4.94700M 51.48M -2.59941M
Ebitda -1306.44500M 268.49M 30.27M 67.16M 14.36M
Depreciation and amortization - 115.19M 35.22M 15.68M 16.95M
Non operating income net other - - - - -
Operating income -178.14700M 153.29M -4.94700M 51.48M -2.59941M
Other operating expenses - 856.92M 581.64M 389.07M 222.44M
Interest expense 13.59M 39.68M 30.90M 24.78M 5.75M
Tax provision -7.18100M -6.54200M -5.60200M -8.45000M -4.45100M
Interest income 33.02M 11.74M 26.05M 27.98M 16.34M
Net interest income -13.58700M -27.94400M -27.97700M -26.34700M 6.58M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -6.54200M -8.97200M 2.82M 0.63M
Total revenue 627.12M 628.37M 513.09M 391.00M 175.25M
Total operating expenses 805.27M 345.37M 191.74M 135.75M 102.94M
Cost of revenue 480.16M 511.56M 389.90M 253.31M 119.50M
Total other income expense net -1258.44700M -593.96900M -340.03900M -109.67579M -8.96378M
Discontinued operations - - - - -
Net income from continuing ops -1443.00000M -434.13200M -336.01400M -84.63400M -16.49900M
Net income applicable to common shares - -476.80100M -367.42100M -102.54000M -25.03700M
Preferred stock and other adjustments - - - - -
Breakdown 2024-05-31 2023-05-31 2022-05-31 2021-05-31 2020-05-31
Type yearly yearly yearly yearly yearly
Date 2024-05-31 2023-05-31 2022-05-31 2021-05-31 2020-05-31
Total assets 4221.66M 4307.26M 5449.69M 6025.36M 1801.23M
Intangible assets 915.47M 973.78M 1277.88M 1605.92M 261.73M
Earning assets - - - - -
Other current assets 31.33M 37.72M 46.79M 48.92M 51.42M
Total liab 778.49M 977.32M 1008.33M 1560.05M 475.89M
Total stockholder equity 3442.91M 3315.69M 4398.81M 4459.07M 1306.74M
Deferred long term liab - - - - -
Other current liab 18.25M 18.04M 119.09M 293.93M 9.24M
Common stock 0.08M - 0.05M 0.05M 1331.54M
Capital stock 0.08M 0.07M 0.05M 0.05M 1331.54M
Retained earnings -2660.48800M -2415.50700M -962.85100M -486.05000M -44.13260M
Other liab - - 196.83M 269.75M 48.45M
Good will 2008.88M 2008.84M 2641.30M 2832.79M 445.50M
Other assets - - 111.51M 8.29M 7.86M
Cash 228.34M 206.63M 415.91M 488.47M 358.47M
Cash and equivalents - - - - -
Total current liabilities 299.17M 432.98M 280.34M 401.24M 122.84M
Current deferred revenue 136.56M - - 155.11M 0.65M
Net debt 158.98M 373.14M 207.90M 450.19M -58.14775M
Short term debt 38.96M - 92.65M 49.60M 7.44M
Short long term debt 33.87M 221.84M 85.95M 45.34M 9.00M
Short long term debt total 387.32M - 623.81M 938.66M 300.32M
Other stockholder equity 6146.81M - 5382.37M 4792.41M 20.24M
Property plant equipment - - 600.50M 668.97M 426.06M
Total current assets 677.71M 773.03M 803.50M 883.61M 651.22M
Long term investments 7.86M 12.37M 15.00M 25.79M 27.02M
Net tangible assets - - 479.62M 20.36M 537.33M
Short term investments 32.18M 241.90M - - 0.00000M
Net receivables 101.69M 86.23M 95.28M 89.79M 50.77M
Long term debt 287.94M 357.93M 519.83M 306.26M 430.21M
Inventory 252.09M 200.55M 245.53M 256.43M 190.56M
Accounts payable 105.39M 70.82M 68.60M 57.71M 110.12M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -43.49900M - -20.76400M 152.67M -0.91488M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 5.39M 0.22M 111.51M 8.29M 0.00000M
Deferred long term asset charges - - - - -
Non current assets total 3543.95M 3534.23M 4646.19M 5141.75M 1150.01M
Capital lease obligations 65.51M 10.36M 18.03M 58.21M 7.14M
Long term debt total - - - 870.59M 444.36M
Breakdown 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Type yearly yearly yearly yearly yearly
Date 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Investments -285.11100M -21.53300M 8.43M 33.94M 47.29M
Change to liabilities - -44.65200M 14.63M 47.32M -0.14500M
Total cashflows from investing activities - -21.53300M 46.10M -69.94600M -134.51700M
Net borrowings - -123.54600M 45.51M 52.29M 356.06M
Total cash from financing activities 70.16M 128.20M 124.31M 125.40M 535.51M
Change to operating activities - 4.47M -6.77200M -10.89900M 4.32M
Net income -1443.00000M -434.13200M -336.01400M -61.01639M -12.19438M
Change in cash -209.27700M -72.55700M 127.82M -38.62458M 362.94M
Begin period cash flow 415.91M 488.47M 360.65M 397.09M 44.15M
End period cash flow 206.63M 415.91M 488.47M 358.47M 407.09M
Total cash from operating activities 7.91M -177.26200M -44.71700M -96.43061M -41.09756M
Issuance of capital stock 129.59M 262.51M 102.55M 71.90M 181.76M
Depreciation 130.15M 154.59M 67.83M 35.52M 16.95M
Other cashflows from investing activities - - 3.33M 19.40M -8.28000M
Dividends paid - - - - -
Change to inventory -12.93400M -45.74900M -35.28600M -90.25428M -29.17443M
Change to account receivables 4.17M -5.84200M -23.51200M -24.73415M 9.21M
Sale purchase of stock -1.18900M - 220.20M 111.52M 228.65M
Other cashflows from financing activities - -1.36100M 87.38M 63.07M 362.16M
Change to netincome - 236.72M 325.73M 45.08M -21.75100M
Capital expenditures 20.80M 34.06M 38.87M 95.47M 152.23M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 14.40M -91.77100M -50.93500M -82.95760M -15.88396M
Stock based compensation 39.59M 35.99M 17.35M 16.22M 19.28M
Other non cash items 258.59M 185.59M 281.92M -2.23709M -46.22690M
Free cash flow -12.89400M -211.32600M -83.59100M -191.90019M -193.32594M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TLRY
Tilray Inc
0.29 16.29% 2.07 - 1000.00 2.17 0.36 1.69 -2.299
BHC
Bausch Health Companies Inc
0.06 0.56% 10.77 - 2.23 0.50 18.74 2.56 9.13
CURA
Curaleaf Holdings Inc.
0.01 0.71% 2.13 - 138.89 1.62 1.66 1.73 10.18
CRON
Cronos Group Inc
0.10 3.58% 2.89 - - 10.18 0.70 0.02 -1.9458
WEED
Canopy Growth Corp
0.10 2.60% 4.14 - - 2.77 1.22 3.58 -1.5049

Reports Covered

Stock Research & News

Profile

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Hiball Energy, Redhook Brewery, Square Mile Cider, Widmer Brothers Brewing, Runner's High Brewing Company, Happy Flower, and Fresh Hemp Foods brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Tilray Inc

265 Talbot Street West, Leamington, ON, Canada, N8H 5L4

Key Executives

Name Title Year Born
Mr. Irwin David Simon Pres, CEO & Chairman 1958
Mr. Carl A. Merton CA, CBV, CPA CFO & Principal Accounting Officer 1970
Mr. Mitchell S. Gendel Global Gen. Counsel & Corp. Sec. 1966
Mr. James R. Meiers Sr. VP of U.S. Operations 1958
Ms. Denise Menikheim Faltischek Chief Strategy Officer & Head of International 1973
Mr. Lloyd Brathwaite Chief Information Officer NA
Mr. Roger Savell Chief Admin. Officer NA
Mr. John B. Sadler VP of Investor Relations NA
Ms. Dara S. Redler Interim Chief Legal Officer & Corp. Sec. NA
Mr. Bernard Yeung Sr. VP of Sales & Marketing NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.